Between-Hospital Variation in Treatment and Outcomes in Extremely Preterm Infants
Top Cited Papers
Open Access
- 7 May 2015
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 372 (19), 1801-1811
- https://doi.org/10.1056/nejmoa1410689
Abstract
Between-hospital variation in outcomes among extremely preterm infants is largely unexplained and may reflect differences in hospital practices regarding the initiation of active lifesaving treatment as compared with comfort care after birth. We studied infants born between April 2006 and March 2011 at 24 hospitals included in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Data were collected for 4987 infants born before 27 weeks of gestation without congenital anomalies. Active treatment was defined as any potentially lifesaving intervention administered after birth. Survival and neurodevelopmental impairment at 18 to 22 months of corrected age were assessed in 4704 children (94.3%). Overall rates of active treatment ranged from 22.1% (interquartile range [IQR], 7.7 to 100) among infants born at 22 weeks of gestation to 99.8% (IQR, 100 to 100) among those born at 26 weeks of gestation. Overall rates of survival and survival without severe impairment ranged from 5.1% (IQR, 0 to 10.6) and 3.4% (IQR, 0 to 6.9), respectively, among children born at 22 weeks of gestation to 81.4% (IQR, 78.2 to 84.0) and 75.6% (IQR, 69.5 to 80.0), respectively, among those born at 26 weeks of gestation. Hospital rates of active treatment accounted for 78% and 75% of the between-hospital variation in survival and survival without severe impairment, respectively, among children born at 22 or 23 weeks of gestation, and accounted for 22% and 16%, respectively, among those born at 24 weeks of gestation, but the rates did not account for any of the variation in outcomes among those born at 25 or 26 weeks of gestation. Differences in hospital practices regarding the initiation of active treatment in infants born at 22, 23, or 24 weeks of gestation explain some of the between-hospital variation in survival and survival without impairment among such patients. (Funded by the National Institutes of Health.)Keywords
This publication has 40 references indexed in Scilit:
- Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' GestationJama-Journal Of The American Medical Association, 2011
- Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research NetworkPediatrics, 2010
- Antenatal Counseling Regarding Resuscitation at an Extremely Low Gestational AgePEDIATRICS, 2009
- Intensive Care for Extreme Prematurity — Moving beyond Gestational AgeThe New England Journal of Medicine, 2008
- Noninitiation or Withdrawal of Intensive Care for High-Risk Newborns: In ReplyPEDIATRICS, 2007
- Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants <32 Weeks’ Gestation Between 1993 and 1998Pediatrics, 2005
- ACOG practice bulletin number 38, September 2002: perinatal care at the threshold of viabilityObstetrics & Gynecology, 2002
- Viability, morbidity, and resource use among newborns of 501- to 800-g birth weight. National Institute of Child Health and Human Development Neonatal Research NetworkJAMA, 1996
- A united states national reference for fetal growthObstetrics & Gynecology, 1996
- A comparison of direct adjustment and regression adjustment of epidemiologic measuresJournal of Chronic Diseases, 1985